Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening
Lorenzo Turcano(IRBM Science Park), Andrea Ilari(Institute of Molecular Biology and Pathology), Trentina Di Muccio(Istituto Superiore di Sanità), Esther Torrente(IRBM Science Park), Antonino Missineo(IRBM Science Park), Gianni Colotti(Institute of Molecular Biology and Pathology), M. Gramiccia(Istituto Superiore di Sanità), Alberto Bresciani(University of Bergamo), Matteo Andreini(Siena Biotech (Italy)), Ilaria Genovese(Italian Institute of Technology), Steven J. Harper(Northwestern University), Annarita Fiorillo(Sapienza University of Rome)
Cited by 68
Related Papers
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease
|Journal of Clinical Investigation|2019|101
Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab
|Clinical Cancer Research|2012|79
Proteolytic Activation Cascade of the Netherton Syndrome–Defective Protein, LEKTI, in the Epidermis: Implications for Skin Homeostasis
|Journal of Investigative Dermatology|2011|75
Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay
|Journal of Huntington s Disease|2017|62